{"id":"https://openalex.org/W7223178222","doi":"https://doi.org/10.3389/fimmu.2026.1991297","title":"Astragaloside IV and tumor microenvironmental barriers: immune mechanisms, evidence hierarchy, and implications for checkpoint blockade","display_name":"Astragaloside IV and tumor microenvironmental barriers: immune mechanisms, evidence hierarchy, and implications for checkpoint blockade","publication_year":2026,"publication_date":"2026-10-22","ids":{"openalex":"https://openalex.org/W7223178222","doi":"https://doi.org/10.3389/fimmu.2026.1991297","pmid":"https://pubmed.ncbi.nlm.nih.gov/42991023","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13735963"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1991297","doi":"https://doi.org/10.3389/fimmu.2026.1991297","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1991297","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1991297/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1991297/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159237998","display_name":"Yingbo Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I160354086","display_name":"Guangxi Medical University","ror":"https://ror.org/03dveyr97","country_code":"CN","type":"education","lineage":["https://openalex.org/I160354086"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yingbo Wang","raw_affiliation_strings":["State Key Laboratory of Targeting Oncology, Guangxi Medical University, National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Targeting Theranostics Research Center of Guangxi Higher Education, Guangxi Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"State Key Laboratory of Targeting Oncology, Guangxi Medical University, National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Targeting Theranostics Research Center of Guangxi Higher Education, Guangxi Medical University","institution_ids":["https://openalex.org/I160354086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159235226","display_name":"Mingyao Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I160354086","display_name":"Guangxi Medical University","ror":"https://ror.org/03dveyr97","country_code":"CN","type":"education","lineage":["https://openalex.org/I160354086"]},{"id":"https://openalex.org/I66867065","display_name":"East China Normal University","ror":"https://ror.org/02n96ep67","country_code":"CN","type":"education","lineage":["https://openalex.org/I66867065"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Mingyao Liu","raw_affiliation_strings":["East China Normal University, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences","State Key Laboratory of Targeting Oncology, Guangxi Medical University, National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Targeting Theranostics Research Center of Guangxi Higher Education, Guangxi Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"East China Normal University, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences","institution_ids":["https://openalex.org/I66867065"]},{"raw_affiliation_string":"State Key Laboratory of Targeting Oncology, Guangxi Medical University, National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Targeting Theranostics Research Center of Guangxi Higher Education, Guangxi Medical University","institution_ids":["https://openalex.org/I160354086"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5159245662","display_name":"Liping Zhong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I160354086","display_name":"Guangxi Medical University","ror":"https://ror.org/03dveyr97","country_code":"CN","type":"education","lineage":["https://openalex.org/I160354086"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Liping Zhong","raw_affiliation_strings":["Pharmaceutical College, Guangxi Medical University","State Key Laboratory of Targeting Oncology, Guangxi Medical University, National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Targeting Theranostics Research Center of Guangxi Higher Education, Guangxi Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical College, Guangxi Medical University","institution_ids":["https://openalex.org/I160354086"]},{"raw_affiliation_string":"State Key Laboratory of Targeting Oncology, Guangxi Medical University, National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Targeting Theranostics Research Center of Guangxi Higher Education, Guangxi Medical University","institution_ids":["https://openalex.org/I160354086"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5159235226","https://openalex.org/A5159245662"],"corresponding_institution_ids":["https://openalex.org/I160354086","https://openalex.org/I66867065"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.58067718,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1991297","last_page":"1991297"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11709","display_name":"Traditional Chinese Medicine Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/astragaloside-iv","display_name":"astragaloside IV","score":0.890999972820282},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9369999766349792},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9629999995231628},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.6309999823570251},{"id":"https://openalex.org/keywords/t-cell-exclusion","display_name":"T-cell exclusion","score":0.7509999871253967},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8230000138282776},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.7910000085830688},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":1.0},{"id":"https://openalex.org/keywords/tumor-vasculature-normalization","display_name":"tumor vasculature normalization","score":0.7820000052452087},{"id":"https://openalex.org/keywords/extracellular-matrix-remodeling","display_name":"extracellular matrix remodeling","score":0.9020000100135803},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.9200000166893005},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5419999957084656},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.3580000102519989}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.724399983882904},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6902999877929688},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6082000136375427},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5964000225067139},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5911999940872192},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4489000141620636},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4426000118255615},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3741999864578247},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.3700000047683716},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3580000102519989},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.35249999165534973},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.3456999957561493},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.30390000343322754},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.30140000581741333},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.2978000044822693},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.27559998631477356},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2694999873638153},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.26930001378059387},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25040000677108765}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D012503","descriptor_name":"Saponins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012503","descriptor_name":"Saponins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014315","descriptor_name":"Triterpenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014315","descriptor_name":"Triterpenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.1991297","doi":"https://doi.org/10.3389/fimmu.2026.1991297","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1991297","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1991297/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmid:42991023","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42991023","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13735963","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13735963/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:3301d5a9d99d4fe182a9ec436401353e","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/3301d5a9d99d4fe182a9ec436401353e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1991297","doi":"https://doi.org/10.3389/fimmu.2026.1991297","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1991297","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1991297/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223178222.pdf","grobid_xml":"https://content.openalex.org/works/W7223178222.grobid-xml"},"referenced_works_count":95,"referenced_works":["https://openalex.org/W1860761105","https://openalex.org/W1975106483","https://openalex.org/W1992112921","https://openalex.org/W2004817662","https://openalex.org/W2006202974","https://openalex.org/W2009690877","https://openalex.org/W2024616781","https://openalex.org/W2033524298","https://openalex.org/W2080202443","https://openalex.org/W2082466127","https://openalex.org/W2087377825","https://openalex.org/W2100039832","https://openalex.org/W2101653483","https://openalex.org/W2110305039","https://openalex.org/W2119896120","https://openalex.org/W2138378181","https://openalex.org/W2160834915","https://openalex.org/W2512318295","https://openalex.org/W2523223625","https://openalex.org/W2560185130","https://openalex.org/W2578528809","https://openalex.org/W2587048937","https://openalex.org/W2615301036","https://openalex.org/W2731227355","https://openalex.org/W2760375764","https://openalex.org/W2778705953","https://openalex.org/W2783703728","https://openalex.org/W2785803176","https://openalex.org/W2791483720","https://openalex.org/W2889143864","https://openalex.org/W2901515128","https://openalex.org/W2912648593","https://openalex.org/W2914311347","https://openalex.org/W2945590213","https://openalex.org/W2959497269","https://openalex.org/W3014748351","https://openalex.org/W3040651070","https://openalex.org/W3093890162","https://openalex.org/W3097206347","https://openalex.org/W3125123581","https://openalex.org/W3127051356","https://openalex.org/W3132259578","https://openalex.org/W3179304282","https://openalex.org/W3194006508","https://openalex.org/W3217789529","https://openalex.org/W4210370153","https://openalex.org/W4214847813","https://openalex.org/W4220987830","https://openalex.org/W4224054997","https://openalex.org/W4225246674","https://openalex.org/W4281707807","https://openalex.org/W4283119957","https://openalex.org/W4291993576","https://openalex.org/W4308584768","https://openalex.org/W4310948993","https://openalex.org/W4319298155","https://openalex.org/W4321241845","https://openalex.org/W4322768225","https://openalex.org/W4323308954","https://openalex.org/W4360616539","https://openalex.org/W4383262854","https://openalex.org/W4385782448","https://openalex.org/W4385986954","https://openalex.org/W4386743565","https://openalex.org/W4386945828","https://openalex.org/W4387779496","https://openalex.org/W4387971855","https://openalex.org/W4388913448","https://openalex.org/W4390673205","https://openalex.org/W4391655333","https://openalex.org/W4392601322","https://openalex.org/W4395071357","https://openalex.org/W4398220502","https://openalex.org/W4401167290","https://openalex.org/W4401643697","https://openalex.org/W4403433100","https://openalex.org/W4403506731","https://openalex.org/W4403695786","https://openalex.org/W4405698852","https://openalex.org/W4406928213","https://openalex.org/W4406973340","https://openalex.org/W4408043117","https://openalex.org/W4408129671","https://openalex.org/W4408751371","https://openalex.org/W4411177606","https://openalex.org/W4413139928","https://openalex.org/W4414162515","https://openalex.org/W4416072235","https://openalex.org/W7117118239","https://openalex.org/W7118065332","https://openalex.org/W7131303612","https://openalex.org/W7148513185","https://openalex.org/W7149642009","https://openalex.org/W7161042166","https://openalex.org/W7162672397"],"related_works":["https://openalex.org/W4308584768","https://openalex.org/W7084159209","https://openalex.org/W3119906275","https://openalex.org/W7204248283","https://openalex.org/W4311271647","https://openalex.org/W2004817662","https://openalex.org/W2277587037","https://openalex.org/W7161042166","https://openalex.org/W2283982146","https://openalex.org/W4387779496"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1,38,123],"inhibitors":[2],"(ICIs)":[3],"have":[4,174],"revolutionized":[5],"cancer":[6],"therapy;":[7],"however,":[8],"primary":[9,107],"and":[10,27,49,81,100,134,155,163,172,202,227,276],"acquired":[11],"resistance":[12],"remain":[13],"prevalent":[14],"in":[15,183,204],"solid":[16],"tumors.":[17],"Challenges":[18],"such":[19],"as":[20,62,74,241],"poor":[21],"T-cell":[22,25,28,154,207],"infiltration,":[23],"spatial":[24,199],"exclusion,":[26],"dysfunction":[29],"present":[30],"distinct":[31],"yet":[32],"interrelated":[33],"obstacles":[34],"that":[35,84],"may":[36,69],"hinder":[37],"blockade":[39],"effectiveness.":[40],"Astragaloside":[41],"IV":[42],"(AS-IV)":[43],"exhibits":[44],"anti-inflammatory,":[45],"antioxidant,":[46],"endothelial-protective,":[47],"antifibrotic,":[48],"metabolism-modulating":[50],"properties":[51],"relevant":[52,267],"to":[53,96,180,246,261],"the":[54,110,151],"tumor":[55,97,221],"microenvironment":[56],"(TME).":[57],"Rather":[58],"than":[59,249],"functioning":[60],"merely":[61],"a":[63,75,242,250],"conventional":[64],"systemic":[65],"immune":[66,98,200],"stimulant,":[67],"AS-IV":[68,95,121,149,171,237],"be":[70,239],"more":[71],"effectively":[72],"viewed":[73,240],"modulator":[76],"of":[77,105,119,169,197,253],"local":[78],"structural,":[79],"cellular,":[80],"metabolic":[82],"conditions":[83],"influence":[85],"checkpoint-blockade":[86],"responsiveness.":[87],"This":[88],"Review":[89],"critically":[90],"examines":[91],"preclinical":[92],"evidence":[93,112],"linking":[94],"regulation":[99],"ICI":[101,132,138,254],"responses.":[102],"A":[103],"total":[104],"twenty":[106],"studies":[108,115,136],"comprise":[109],"core":[111],"base:":[113],"six":[114],"evaluating":[116],"direct":[117,131],"combinations":[118,139,168],"free":[120,170],"with":[122,150],"blockade,":[124],"nine":[125],"representative":[126],"tumor-specific":[127,263],"mechanistic":[128],"investigations":[129],"without":[130],"testing,":[133],"five":[135],"on":[137,220,231],"utilizing":[140],"AS-IV-containing":[141],"formulations":[142],"or":[143,209,233],"delivery":[144],"systems.":[145],"Tumor-specific":[146],"findings":[147],"connect":[148],"PPP1R14B/CX3CL1/CD8":[152],"+":[153,206],"MCT1/lactate":[156],"pathways,":[157],"macrophage-associated":[158],"states,":[159],"cancer-associated":[160],"fibroblast":[161],"activity,":[162],"context-dependent":[164],"PD-L1":[165],"regulation.":[166],"Direct":[167],"ICIs":[173,247],"demonstrated":[175],"superior":[176],"antitumor":[177],"activity":[178],"compared":[179],"respective":[181],"monotherapies":[182],"several":[184],"models,":[185],"though":[186],"formal":[187],"pharmacological":[188],"synergy":[189],"remains":[190],"unproven.":[191],"Most":[192],"models":[193],"lacked":[194],"adequate":[195],"characterization":[196],"pretreatment":[198],"phenotypes,":[201,272],"increases":[203],"CD8":[205],"measures":[208],"combination":[210,255,277],"benefits":[211],"post-treatment":[212],"do":[213],"not":[214],"confirm":[215],"\u201ccold-to-hot\u201d":[216],"conversion.":[217],"Proposed":[218],"effects":[219],"vascular":[222],"normalization,":[223],"ECM":[224],"remodeling,":[225],"perfusion,":[226],"hypoxia":[228],"primarily":[229],"rely":[230],"indirect":[232],"cross-contextual":[234],"evidence.":[235],"Thus,":[236],"should":[238],"potential":[243],"TME-modulating":[244],"adjunct":[245],"rather":[248],"well-established":[251],"component":[252],"therapy.":[256],"Further":[257],"research":[258],"is":[259],"necessary":[260],"delineate":[262],"causal":[264],"mechanisms,":[265],"pharmacologically":[266],"exposure":[268],"levels,":[269],"responsive":[270],"TME":[271],"optimal":[273],"treatment":[274],"schedules,":[275],"safety.":[278]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}